A continuación se presenta un resumen de las declaraciones de intereses de los dos últimos años. Una información más detallada se encuentra en la página web de la IMS.
R. J. Baber
Obstetrics and Gynaecology, Sydney Medical School North, The University of Sydney, Sydney, Australia
Junta Consultiva y/o Consultor: Pfizer
Conferenciante para: Abbott 56
N. Panay
Imperial College London, UK, Co-Editor-in-Chief, Climacteric
Junta Consultiva y/o Consultor: Abbott, Bayer,Besins, Novo Nordisk, Pfizer, Shionogi
Conferenciante para: Abbott, Bayer, Besins, Novo
Nordisk
A. Fenton
Christchurch Women’s Hospital, Christchurch, New Zealand, Co-Editor-in-Chief, Climacteric
Junta Consultiva y/o Consultor: Pfizer
Conferenciante para: Besins, Mylan
L. Cardozo
Professor of Urogynaecology, King’s College
Hospital, London, UK
Junta Consultiva y/o Consultor: Astellas, BMR, Golin Health
Conferenciante para: Allergan, Astellas
Asignación para investigación: Pfizer
C. Castelo-Branco
Clinic Institute of Gynecology, Obstetrics and Neonatology, Faculty of Medicine, University of Barcelona, Barcelona, Spain
Junta Consultiva y/o Consultor: Pierre Fabre, Shionogi
Conferenciante para: Amgem, Isdin, Pfizer, Pierre
Fabre, Shionogi
S. R. Davis
Women’s Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Junta Consultiva y/o Consultor: Abbott International, Pfizer, Acerus Pharmaceuticals
Asignación para investigación: Lawley Pharmaceuticals
T. J. de Villiers
MediClinic Panorama and Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa
Junta Consultiva y/o Consultor: Adcock Ingram Ltd, Merck, Pfizer
Conferenciante para: Adcock Ingram Ltd, Pfizer
S. R. Goldstein
Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA
Junta Consultiva y/o Consultor: AbbVie, Amgen,
Cook ObGyn, JDS Therapeutics, Pfizer, Radius Health Inc, Sermonix Pharmaceuticals, Shionogi Ltd
Conferenciante para: JDS Therapeutics, Pfizer and Shionogi Consultor mediante préstamo de equipamiento: Philips Ultrasound
A. Gompel
UF de Gynécologie, Université Paris Descartes, AP-HP, Hopitaux Paris Centre, Port Royal Cochin, INSERM U1007, Paris, France
Sin relaciones financieras relevantes
V. W. Henderson
Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences, Stanford University, Stanford, CA, USA Asignación para investigación: NIH
Reembolso para viaje de: Academia Americana de Neurología, Sociedad Interancional de Menopausia para participar en reuniones de los comités de las mismas
H. N. Hodis
Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, USA
Asignación para investigación: NIH como investigador Principal
R. D. Langer
Associate Dean for Clinical and Translational Research and Professor of Family Medicine-Las Vegas, University of Nevada School of Medicine, Las Vegas, NV, USA
Consultor sobre litigios: Roche Pharmaceuticals
R. A. Lobo
Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA
Conferenciante para: Pfizer
Asignación para investigación: Therapeutics MD
P. M. Maki
Departments of Psychiatry and Psychology, University of Illinois at Chicago, USA
Conferenciante para: Abbott, Noven
A. O. Mueck
Department of Women’s Health, Germany and Capital Medical University, Beijing OB/GYN Hospital, WHO Centre, China
Sin relaciones financieras relevantes
R. E. Nappi
Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause,
IRCCS S. Matteo Foundation, University of Pavia, Pavia, Italy
Junta Consultiva y/o Consultor: Bayer HealthCare, Gedeon Richter, Merck Sharpe & Dohme, Shionogi Ltd 58
Conferenciante para: Novo Nordisk, Pfizer, Shionogi Ltd, TEVA Women’s Health Inc
Asignación para investigación: Bayer HealthCare
A. Pines
Sackler Faculty of Medicine, Tel-Aviv University,
Tel-Aviv, Israel
Sin relaciones financieras relevantes
G. Plu-Bureau
Department of Gynecology, Hopitaux Universitaires
Paris Centre, Paris Descartes University, Paris, France
Sin relaciones financieras relevantes
D. Robinson
Department of Urogynaecology, King’s College Hospital, London, UK
Junta Consultiva y/o Consultor: Astellas,Pfizer, Allergan, Ferring
Conferenciante para: Astellas, Pfizer, Allergan Asignación para investigación: Astellas, Pfizer, Allergan
T. Simoncini
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Junta Consultiva y/o Consultor: Abbott, Actavis
Conferenciante para: Abbott, Actavis
S. Z. Vujovic
Medical Faculty, University of Belgrade and Clinic of Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, Belgrade, Serbia.
Sin relaciones financieras relevantes
Fuente de financiamiento Los costes de la producción de este manuscrito han sido subsidiados completamente con fondos de la Sociedad Internacional de Menopausia.
* Correspondencia: Profesor R. J. Baber, Obstetrics and Gynaecology, Sydney Medical School North, The University of Sydney, Sydney, Australia; email: rod@rodbaber.com.au(c) 2016 Sociedad Internacional de Menopausia.
** Colaboradores de esta versión en español.
